<DOC>
	<DOCNO>NCT01251744</DOCNO>
	<brief_summary>This study design evaluate maternal virological immunological parameter determine ability predict congenital cytomegalovirus ( CMV ) infection . When pregnant woman infect CMV , immune system ( protect infection ) activate virus find woman 's bodily fluid ( blood , saliva , urine , vaginal secretion ) . The aim study find link either pregnant woman 's immune response presence virus bodily fluids child/foetus infected virus .</brief_summary>
	<brief_title>Study Transmission Cytomegalovirus ( CMV ) Infection From Mother Foetus</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Cytomegalovirus Infections</mesh_term>
	<criteria>Subjects investigator believe comply requirement protocol . A pregnant female , 18 year age old time study enrolment . Women confirm primary CMV infection . Written inform consent obtain subject . Chronic administration immunosuppressant immunemodifying drug within six month prior study entry . Concurrently participate another clinical study , time study period , subject expose investigational noninvestigational pharmaceutical product . Previous vaccination CMV infection . Any confirm suspected immunosuppressive immunodeficient condition , base medical history physical examination Major congenital defect , serious chronic illness organ transplantation . Administration immunoglobulins and/or blood product within three month precede study enrolment pregnancy . Documented Human immunodeficiency virus ( HIV ) positive subject . Gestational age 34 week , determine foetal ultrasound .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Pregnancy</keyword>
	<keyword>Congenital</keyword>
	<keyword>Cytomegalovirus infection</keyword>
</DOC>